AlphaStocks
3.4
Weak

Alcon Inc (ALC)

As of Sep 20, 2026, Alcon Inc (ALC) scores 3.4/10 on AlphaStocks' five-model composite, #153 of 168 Health Care stocks. At $65, ALC trades 21% above its model fair value of $54.

Health Care

ADR

$65.06

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#153out of 168 in Health Care

Is ALCON INC a Good Investment in 2026?

ALCON INC (ALC) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates ALCON INC as Attractive (6/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. ALCON INC currently trades 21% above its estimated fair value of $54. ALCON INC ranks #153 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E32.9ROE4.4Market Cap32B

Estimated Fair Value

$53.7921% above

Trading above estimated fair value. Eps growth of -3% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

53% above fair value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Neutral

Earnings yield 3.7% · ROC 17%

Frequently Asked Questions

Is ALCON INC (ALC) a good investment?
As of Sep 20, 2026, Alcon Inc (ALC) scores 3.4/10 on AlphaStocks' five-model composite, #153 of 168 Health Care stocks. At $65, ALC trades 21% above its model fair value of $54. That score is below average, suggesting caution.
What is ALCON INC's Piotroski F-Score?
ALCON INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ALC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $54, ALC appears overvalued. The stock currently trades 21% above its estimated fair value. Trading above estimated fair value. Eps growth of -3% may not justify the premium.
How does ALC compare to other Health Care stocks?
ALCON INC ranks #153 out of 168 stocks in the Health Care sector, placing it in the top 91% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ALC?
AlphaStocks evaluates ALC using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 3.4/10.

Similar Stocks

INSPABBVINCY

Compare ALC with

ALC vs INSPABBV vs ALCALC vs INCYALC vs PARRALC vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer